Loading clinical trials...
Loading clinical trials...
The goal of this observational, multicenter, descriptive, prospective, and longitudinal study is to evaluate the impact of IBD activity on frailty in a prospective and longitudinal cohort of patients ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
NCT07385807 · IBD (Inflammatory Bowel Disease), IBD, and more
NCT06833957 · Group B Streptococcus, Invasive Bacterial Diseases (IBD), and more
NCT07245394 · Inflammatory Bowel Disease (IBD), Crohn Disease (CD), and more
NCT07089420 · IBD (Inflammatory Bowel Disease), IBS - Irritable Bowel Syndrome, and more
NCT05698745 · Crohn Disease, Ulcerative Colitis, and more
Hospital Universitario Araba
Vitoria-Gasteiz, Alava
Hospital Germans Trias i Pujol
Badalona, Barcelona
Hospital de Bellvitge
L'Hospitalet de Llobregat, Barcelona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions